Previous studies have identified the crucial role of TRIP13 in tumor immunity, where it supports tumor survival by modulating the recruitment of immune cells, including CD3+, CD4+, and CD8+ T cells, into the tumor microenvironment [23]. The gene discussed is CD4; the disease is neoplasm.